Convalescent plasma (CP) from patients recovered from COVID-19 is one of the most
studied anti-viral therapies against SARS-COV-2 infection. The aim of this study is to …

Background: The coronavirus disease (COVID-19), caused by the Severe Acute Respiratory
Syndrome Coronavirus-2 (SARS-CoV-2), prompted a global health crisis, with no available …

Background There is still a lack of consensus on the efficacy of convalescent plasma (CP)
treatment in COVID‐19 patients. We performed a systematic review and meta‐analysis to …

Convalescent plasma (CP) recurs as a frontline treatment in epidemics because it is
available as soon as there are survivors. The COVID-19 pandemic represented the first …

Importance COVID-19 convalescent plasma (CCP) is a potentially beneficial treatment for
COVID-19 that requires rigorous testing. Objective To compile individual patient data from …

Background: Coronavirus disease 2019 (COVID-19), sweeping across the world, has
created a worldwide pandemic. Effective treatments of COVID-19 are extremely urgent …

The objective of this study was to assess whether convalescent plasma therapy could offer
survival advantages for patients with novel coronavirus disease 2019 (COVID-19). An …

BACKGROUND: The safety and efficacy of convalescent plasma in severe coronavirus
disease 2019 (COVID-19) remain uncertain. To support a guideline on COVID-19 …

Convalescent plasma is a suggested treatment for Coronavirus disease 2019 (Covid-19),
but its efficacy is uncertain. We aimed to evaluate whether the use of convalescent plasma is …

Plasma collected from people recovered from COVID-19 (COVID-19 convalescent plasma,
CCP) was the first antibody-based therapy employed to fight the pandemic. CCP was …